RINDERON Side Effects

6407409-5 | Liver Disorder
on Oct 08, 2009 Female patient from JAPAN , 52 years of age, weighting 79.37 lb, was diagnosed with insomnia and was treated with Rinderon (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Rinderon dosage: Unk. During the same period patient was treated with FAMOTIDINE (20 Mg) (View Famotidine Review and Famotidine Label ), ATARAX (25 Mg) (View Atarax Review and Atarax Label ), ZYRTEC (10 Mg) (View Zyrtec Review and Zyrtec Label ), MYSLEE (View Myslee Review and Myslee Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

6382506-1 | Hepatitis Acute
Patient was taking Rinderon (View Usage). Patient had the following side effects: hepatitis acute on Sep 18, 2009 from JAPAN Additional patient health information: Female patient , 50 years of age, . Rinderon dosage: Unk. During the same period patient was treated with FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ), ZYRTEC (Unk) (View Zyrtec Review and Zyrtec Label ), MYSLEE (Unk) (View Myslee Review and Myslee Label ), ALLEGRA (Unk) (View Allegra Review and Allegra Label ). Patient was hospitalized.

5235609-9 | Disease Progression, Respiratory Disorder
Adverse event was reported on Feb 07, 2007 by a Male patient taking Rinderon (View Usage) (Dosage: 1 Mg, Unk) was diagnosed with lung neoplasm malignant, prophylaxis, cancer pain, hypercalcaemia of malignancy, angina pectoris and. Location: JAPAN , 73 years of age, After Rinderon was administered, patient had the following side effects: disease progression, respiratory disorder. During the same period patient was treated with PROTECADIN (10 Mg, Unk) (View Protecadin Review and Protecadin Label ), ETOPAN (400 Mg, Unk) (View Etopan Review and Etopan Label ), ZOMETA (4 Mg, Unk) (View Zometa Review and Zometa Label ), NIKORANMART (15 Mg, Unk) (View Nikoranmart Review and Nikoranmart Label ).

5015164-9 | Acute Coronary Syndrome, Agitation, Asthenia, Chest Discomfort, Dyspnoea, Erythema, Headache, Nasopharyngitis, Nausea
on May 17, 2006 Female patient from JAPAN , 61 years of age, was diagnosed with status asthmaticus and was treated with Rinderon (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, agitation, asthenia, chest discomfort, dyspnoea, erythema, headache (What is headache?), nasopharyngitis, nausea (What is nausea?). Rinderon dosage: 6 Mg-4mg* Intravenous. During the same period patient was treated with REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), TULOBUTEROL (View Tulobuterol Review and Tulobuterol Label ), ASTHMOLYSIN D (View Asthmolysin D Review and Asthmolysin D Label ), ONON (PANLUKAST) (View Onon (panlukast) Review and Onon (panlukast) Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), HUSTAZOL (View Hustazol Review and Hustazol Label ).


4866773-9 | Pneumonia Legionella, Pulmonary Tuberculosis
on Dec 12, 2005 Male patient from JAPAN , 77 years of age, was diagnosed with brain oedema and was treated with Rinderon (View Usage). Patient had the following side effects: pneumonia legionella, pulmonary tuberculosis. Rinderon dosage: 2-4 Mg Oral; 4 Mg, Oral; 3 Mg Oral; 2mg Oral. During the same period patient was treated with LORNOXICAM (CHLOROTENOXIPAM) (View Lornoxicam (chlorotenoxipam) Review and Lornoxicam (chlorotenoxipam) Label ), TIZANIDINE HYDROCHOLORIDE (View Tizanidine Hydrocholoride Review and Tizanidine Hydrocholoride Label ), LORMETAZEPAM (View Lormetazepam Review and Lormetazepam Label ). Patient was hospitalized.

4592692-1 | Constipation, Diarrhoea, Duodenal Ulcer Perforation, Intestinal Hypomotility, Leukopenia, Malaise, Peritonitis
Patient was taking Rinderon (View Usage). After Rinderon was administered, patient had the following side effects: constipation (What is constipation?), diarrhoea, duodenal ulcer perforation, intestinal hypomotility, leukopenia, malaise, peritonitis on Feb 10, 2005 from Additional patient health information: Male patient , 71 years of age, was diagnosed with nausea (What is nausea?), cancer pain, diarrhoea and. Rinderon dosage: 3-5 Mg Qd Oral. During the same period patient was treated with MS CONTIN (20-30 Mg) (View Ms Contin Review and Ms Contin Label ), VOLTAREN (75 Mg) (View Voltaren Review and Voltaren Label ), LOPEMIN (2 Mg) (View Lopemin Review and Lopemin Label ).